Clinical manifestations and treatment of chronic eosinophilic leukemia (CEL)/idiopathic hypereosinophilic syndrome (HES) in Japan

Saved in:
Bibliographic Details
Published inRinshō ketsueki Vol. 51; no. 7; p. 515
Main Authors Sada, Akiko, Matsui, Toshimitsu
Format Journal Article
LanguageJapanese
Published Japan 01.07.2010
Subjects
Antineoplastic Agents - therapeutic use
Benzamides
Chronic Disease
Humans
Hypereosinophilic Syndrome - diagnosis
Hypereosinophilic Syndrome - physiopathology
Hypereosinophilic Syndrome - therapy
Imatinib Mesylate
mRNA Cleavage and Polyadenylation Factors
Piperazines - therapeutic use
Pyrimidines - therapeutic use
Receptor, Platelet-Derived Growth Factor alpha
Recombinant Fusion Proteins
Reference Standards
Online AccessGet more information

Cover

More Information
ISSN:0485-1439
DOI:10.11406/rinketsu.51.515